Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients

Aging Cell

Volumn 12, Issue 3, 2013, Pages 459-466

  Fontana, Luigi ^a,b,c   Addante, Filomena ^d   Copetti, Massimiliano ^d   Paroni, Giulia ^d   Fontana, Andrea ^d   Sancarlo, Daniele ^d   Pellegrini, Fabio ^d,e   Ferrucci, Luigi ^f   Pilotto, Alberto ^d,g  

^a UNIVERSITY OF SALERNO   (Italy)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^d CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^e Santa Maria Imbaro   (Italy)

^f HARBOR HOSPITAL   (United States)

^g S ANTONIO HOSPITAL   (Italy)

Author keywords

Comprehensive geriatric assessment; IGF 1; Inflammation; Mortality; Multidimensional prognostic index; Testosterone

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; GLUCOSE; HEMOGLOBIN; IRON; LIOTHYRONINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SOMATOMEDIN C;

AGED; AGED HOSPITAL PATIENT; ALBUMIN BLOOD LEVEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; COGNITIVE DEFECT; DOWN REGULATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GERIATRIC ASSESSMENT; HUMAN; IRON BLOOD LEVEL; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; AGING; BIOLOGICAL MARKERS; BLOOD SEDIMENTATION; C-REACTIVE PROTEIN; CHOLESTEROL, LDL; FEMALE; FRAIL ELDERLY; HORMONES; HOSPITALIZATION; HUMANS; INFLAMMATION; INSULIN-LIKE GROWTH FACTOR I; IRON; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; MALE; MORTALITY; PROPORTIONAL HAZARDS MODELS; SERUM ALBUMIN; TRIIODOTHYRONINE;

EID: 84877832333     PISSN: 14749718     EISSN: 14749726     Source Type: Journal    
DOI: 10.1111/acel.12068     Document Type: Article

References (49)

1. Antebi A (2012) Regulation of longevity by the reproductive system. Exp. Gerontol. doi: 10.1016/j.exger.2012.09.009. [Epub ahead of print].
2. Bartke A (2005) Minireview: role of the growth hormone/insulin-like system in mammalian aging. Endocrinology 146, 3718-3723.
3. Black PH (2003) The inflammatory response is an integral part of the stress response: implications for atherosclerosis, insulin resistance, type II diabetes and metabolic syndrome X. Brain Behav. Immun. 17, 350-364.
4. Bliss MR, McLaren R, Exton-Smith AN (1966) Mattresses for preventing pressure sores in geriatric patients. Mon. Bull. Minist. Health Public Health Lab. Serv. 25, 238-268.
5. Cangemi R, Friedmann AJ, Holloszy JO, Fontana L (2010) Effects of long-term calorie restriction on serum sex hormones concentration in men. Aging Cell 9, 236-242.
6. Cawthon PM, Ensrud KE, Laughlin GA, Cauley JA, Dam TT, Barrett-Connor E, Fink HA, Hoffman AR, Lau E, Lane NE, Stefanick ML, Cummings SR, Orwoll ES, Osteoporotic Fractures in Men (MrOS) Research Group (2009) Sex hormones and frailty in older men: the Osteoporotic Fractures in Men (MrOS) Study. J. Clin. Endocrinol. Metab. 94, 3806-3815.
7. Cohen HJ, Pieper CF, Harris T, Rao KM, Currie MS (1997) The association of plasma IL-6 levels with functional disability in community-dwelling elderly. J. Gerontol. A Biol. Sci. Med. Sci. 52, M201-M208.
8. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420, 860-867.
9. Ershler WB, Sun WH, Binkley N, Gravenstein S, Volk MJ, Kamoske G, Klopp RG, Roecker EB, Daynes RA, Weindruch R (1993) Interleukin-6 and aging: blood levels and mononuclear cell production increase with advancing age and in vitro production is modifiable by dietary restriction. Lymphokine Cytokine Res. 12, 225-230.
10. Fontana L, Klein S (2007) Aging, adiposity and calorie restriction. JAMA 297, 986-994.
11. Fontana L, Meyer TE, Klein S, Holloszy JO (2004) Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans. Proc. Natl Acad. of Sci. USA 101, 6659-6663.
12. Fontana L, Klein S, Holloszy JO, Premachandra BN (2006) Effect of long-term calorie restriction with adequate protein and micronutrients on thyroid hormones. J. Clin. Endocrinol. Metab. 91, 3232-3235.
13. Fontana L, Weiss EP, Villareal D, Klein S, Holloszy JO (2008) Long-term effects of calorie or protein restriction on serum IGF-1 and IGFBP-3 concentration in humans. Aging Cell 7, 681-687.
14. Fontana L, Partridge L, Longo VD (2010) Extending healthy life span-from yeast to humans. Science 328, 321-326.
15. Franceschi C, Bonafe M (2003) Centenarians as a model for healthy aging. Biochem. Soc. Trans. 31, 457-461.
16. Friedrich N, Haring R, Nauck M, Lüdemann J, Rosskopf D, Spilcke-Liss E, Felix SB, Dörr M, Brabant G, Völzke H, Wallaschofski H (2009) Mortality and serum insulin-like growth factor (IGF)-I and IGF binding protein 3 concentrations. J. Clin. Endocrinol. Metab. 94, 1732-1739.
17. Gill TM, Gahbauer EA, Han L, Allore HG (2010) Trajectories of disability in the last year of life. N. Engl. J. Med. 362, 1173-1180.
18. Guigoz Y, Vellas B (1999) The Mini Nutritional Assessment (MNA) for grading the malnutrition states of elderly patients: presentation of the MNA, history and validation. Nestle. Nutr. Workshop Ser. Clin. Perform. Programme. 1, 3-11.
19. Harris TB, Ferrucci L, Tracy RP, Corti MC, Wacholder S, Ettinger WH Jr, Heimovitz H, Cohen HJ, Wallace R (1999) Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am. J. Med. 106, 506-512.
20. Katz S, Downs TD, Cash HR, Grotz RC (1970) Progress in the development of an index of ADL. Gerontologist 10, 20-30.
21. Lamberts SW, van den Beld AW, van der Lely AJ (1997) The endocrinology of aging. Science 278, 419-424.
22. Laughlin GA, Barrett-Connor E, Bergstrom J (2008) Low serum testosterone and mortality in older men. J. Clin. Endocrinol. Metab. 93, 68-75.
23. Lawton MP, Brody EM (1969) Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 9, 179-186.
24. Lee SJ, Lindquist K, Segal MR, Covinsky KE (2006) Development and validation of a prognostic index for 4-year mortality in older adults. JAMA 295, 801-808.
25. Leng SX, Hung W, Cappola AR, Yu Q, Xue QL, Fried LP (2009) White blood cell counts, insulin-like growth factor-1 levels, and frailty in community-dwelling older women. J. Gerontol. A Biol. Sci. Med. Sci. 64, 499-502.
26. Linn B, Linn M, Gurel L (1968) The cumulative illness rating scale. J. Am. Geriatr. Soc. 16, 622-626.
27. Maggio M, Cappola AR, Ceda GP, Basaria S, Chia CW, Valenti G, Ferrucci L (2005) The hormonal pathway to frailty in older men. J. Endocrinol. Invest. 28, 15-19.
28. McGinn TG, Guyatt GH, Wyer PC, Naylor CD, Stiell IG, Richardson WS (2000) Evidence-Based Medicine Working Group. Users' guides to the medical literature: XXII: how to use articles about clinical decision rules. JAMA 284, 79-84.
29. Paganelli R, Di Iorio A, Cherubini A, Lauretani F, Mussi C, Volpato S, Abate M, Abate G, Ferrucci L (2006) Frailty of older age: the role of the endocrine - immune interaction. Curr. Pharm. Des. 12, 3147-3159.
30. Pencina MJ, D'Agostino RB (2004) Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat. Med. 23, 2109-2123.
31. Pencina MJ, D'Agostino RB, Vasan RS (2008) Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med. 27, 157-172.
32. Pencina MJ, D'Agostino RB, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat. Med. 30, 11-21.
33. Pfeiffer E (1975) A short portable mental status questionnaire for the assessment of organic brain deficit in elderly patients. J. Am. Geriatr. Soc. 23, 433-441.
34. Pilotto A, Ferrucci L, Franceschi M, D'Ambrosio LP, Scarcelli C, Cascavilla L, Paris F, Placentino G, Seripa D, Dallapiccola B, Leandro G (2008) Development and validation of a multidimensional prognostic index for 1-year mortality from the comprehensive geriatric assessment in hospitalized older patients. Rejuvenation Res. 11, 151-161.
35. Pilotto A, Addante F, Ferrucci L, Leandro G, D'Onofrio G, Corritore M, Niro V, Scarcelli C, Dallapiccola B, Franceschi M (2009a) The Multidimensional Prognostic Index (MPI) predicts short and long-term mortality in older patients with community-acquired pneumonia. J. Gerontol. A Biol. Med. Sci. 64, 880-887.
36. Pilotto A, Sancarlo D, Panza F, Paris F, D'Onofrio G, Cascavilla L, Addante F, Seripa D, Solfrizzi V, Dallapiccola B, Franceschi M, Ferrucci L (2009b) The Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term mortality in hospitalized older patients with dementia. J. Alzheimers. Dis. 18, 191-199.
37. Pilotto A, Addante F, Franceschi M, Leandro G, Rengo G, D'Ambrosio P, Longo MG, Rengo F, Pellegrini F, Dallapiccola B, Ferrucci L (2010) A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short-term mortality in older patients with heart failure. Circ. Heart Fail. 3, 14-20.
38. Pilotto A, Rengo F, Marchionni N, Sancarlo D, Fontana A, Panza F, Ferrucci L, FIRI-SIGG Study Group (2012) Comparing the prognostic accuracy for all-cause mortality of frailty instruments: a multicentre 1-year follow-up in hospitalized older patients. PLoS ONE 7, e29090.
39. Puts MT, Visser M, Twisk JW, Deeg DJ, Lips P (2005) Endocrine and inflammatory markers as predictors of frailty. Clin. Endocrinol. 63, 403-411.
40. Reichlin S (1993) Neuroendocrine-immune interactions. N. Engl. J. Med. 329, 1246-1253.
41. Rockwood K, Mitnitski A, Song X, Steen B, Skoog I (2006) Long-term risks of death and institutionalization of elderly people in relation to deficit accumulation at age 70. J. Am. Geriatr. Soc. 54, 975-979.
42. Ross R (1999) Atherosclerosis-an inflammatory disease. N. Engl. J. Med. 340, 115-126.
43. Sancarlo D, Pilotto A, Panza F, Copetti M, Longo MG, D'Ambrosio P, D'Onofrio G, Ferrucci L, Pilotto A (2012) A Multidimensional Prognostic Index (MPI) based on a comprehensive geriatric assessment predicts short- and long-term all-cause mortality in older hospitalized patients with transient ischemic attack. J. Neurol. 259, 670-678.
44. Siontis GC, Tzoulaki I, Ioannidis JP (2011) Predicting death: an empirical evaluation of predictive tools for mortality. Arch. Intern. Med. 171, 1721-1726.
45. Walston J, McBurnie MA, Newman A, Tracy RP, Kop WJ, Hirsch CH, Gottdiener J, Fried LP, Cardiovascular Health Study (2002) Cardiovascular Health Study. Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study. Arch. Intern. Med. 162, 2333-2341.
46. Weindruch R, Walford RL (1988) The Retardation of Aging and Disease by Dietary Restriction. Springfield, IL: Charles C Thomas Publisher.
47. Willcox BJ, He Q, Chen R, Yano K, Masaki KH, Grove JS, Donlon TA, Willcox DC, Curb JD (2006) Midlife risk factors and healthy survival in men. JAMA 296, 2343-2350.
48. Wyss-Coray T (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12, 1005-1015.
49. Yourman LC, Lee SJ, Schonberg MA, Widera EW, Smith AK (2012) Prognostic indices for older adults: a systematic review. JAMA 307, 182-192.